Categories: CoronavirusWorld News

Russia Aims To Produce ‘Millions’ Of Vaccine Doses By 2021

In this file photo taken on May 18, 2020, a syringe is pictured on an illustration representation of COVID-19, the disease caused by the novel coronavirus in Paris.  JOEL SAGET / AFP

 

 

 

Russia said Monday it aims to launch mass production of a coronavirus vaccine next month and turn out “several million” doses per month by next year.

The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stages of development and is about to pass state registration, officials said.

“We are very much counting on starting mass production in September,” Industry Minister Denis Manturov said in an interview published by state news agency TASS.

“We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year,” he said, adding that one developer is preparing production technology at three locations in central Russia.

 

File photo: Medical workers transport a woman into a hospital where patients infected with the COVID-19 novel coronavirus are being treated in the settlement of Kommunarka outside Moscow on April 27, 2020. Alexander NEMENOV / AFP.

 

The head of the Russian Direct Investment Fund, which finances the trials, said he expects official registration of the vaccine to be complete “within ten days.”

“If this happens in the next ten days, we will be ahead not just of the United States but other countries too, it will be the first registered coronavirus vaccine,” RDIF chief Kirill Dmitriev said in televised remarks.

Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Health Minister Mikhail Murashko said on Saturday.

Gamaleya’s vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding the needed immune response into cells.

Gamaleya’s vaccine is based on the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China’s CanSino, currently in the advanced stage of clinical trials.

– ‘Who will buy it?’ –

The state-run Gamaleya institute came under fire after researchers and its director injected themselves with the prototype several months ago, with specialists criticising the move as an unorthodox and rushed way of starting human trials.

Vitaly Zverev, laboratory chief at the Mechnikov Research Institute of Vaccines and Sera, said it was too early to register a vaccine.

 

File photo: Health workers wearing protective equipment arrive with a man wearing a face mask past an ambulance at a hospital where patients infected with the COVID-19 are being treated in Khimki, outside Moscow on May 3, 2020, amid the COVID-19 outbreak, caused by the novel coronavirus. Kirill KUDRYAVTSEV / AFP.

 

“I believe a vaccine that is not properly checked must not be registered, no matter in what country,” he said.

“It is impossible to ensure the vaccine’s safety in the time that has passed since the beginning of this pandemic,” he told AFP.

“You can make anything, but who is going to buy it?”

Zverev added that the three firms named as future producers of Russia’s vaccines are well-known pharmaceutical firms that do not normally make vaccines, let alone high-tech ones using DNA technology.

“No adenovirus-based vaccine has been proven effective before,” he said. “How are they going to grow it? Nobody explains this.”

Moscow has dismissed allegations from the UK, the United States and Canada that a hacking group linked to Russian intelligence services tried to steal information about a coronavirus vaccine from labs in the West.

At more than 850,000 infections, Russia’s coronavirus caseload is currently fourth in the world after the United States, Brazil and India.

AFP

Emmanuel Egobiambu

Disqus Comments Loading...

Recent Posts

Nigerian Manufacturers Ready To Produce Vaccines, Tinubu Tells Gavi CEO

Tinubu stated that his administration is focused on ensuring that no child is left behind…

4 hours ago

Hat-Trick Hero Palmer Snatches Victory From Man United In Dramatic EPL Showdown

Man United were close to a famous comeback after going two goals down. But the…

5 hours ago

Thieves Steal $30m Cash In Los Angeles Heist

While the crime is reminiscent of Hollywood heist movies like "Ocean's Eleven," it follows a…

5 hours ago

Mac Allister Fires Liverpool Back To EPL Summit Ahead Man United Showdown

Liverpool head to Manchester United in the league on Sunday for a crucial clash with…

5 hours ago

VIDEO: Troops Killed 2,351 Terrorists In Q1 2024 – DHQ

The Director of Defence Media Operations, Major General Edward Buba said this during a media…

5 hours ago

LG Polls: Bayelsa Govt Declares Friday Work-Free Day

Ahead of the election, political parties apart from the ruling Peoples Democratic Party (PDP) in…

6 hours ago